A detailed history of Geneva Partners, LLC transactions in Mckesson Corp stock. As of the latest transaction made, Geneva Partners, LLC holds 8,390 shares of MCK stock, worth $4.07 Million. This represents 2.05% of its overall portfolio holdings.

Number of Shares
8,390
Previous 8,570 2.1%
Holding current value
$4.07 Million
Previous $4.6 Million 6.52%
% of portfolio
2.05%
Previous 2.06%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$518.81 - $607.81 $93,385 - $109,405
-180 Reduced 2.1%
8,390 $4.9 Million
Q1 2024

Apr 30, 2024

BUY
$473.42 - $539.26 $4,734 - $5,392
10 Added 0.12%
8,570 $4.6 Million
Q4 2023

Jan 31, 2024

SELL
$437.42 - $470.64 $826,723 - $889,509
-1,890 Reduced 18.09%
8,560 $3.96 Million
Q3 2023

Oct 25, 2023

BUY
$402.4 - $446.42 $2.89 Million - $3.21 Million
7,187 Added 220.26%
10,450 $4.54 Million
Q2 2023

Aug 03, 2023

BUY
$354.01 - $427.31 $1.16 Million - $1.39 Million
3,263 New
3,263 $1.39 Million
Q4 2022

Jan 23, 2023

SELL
$346.68 - $397.58 $286,011 - $328,003
-825 Reduced 13.03%
5,508 $0
Q3 2022

Oct 31, 2022

BUY
$321.25 - $373.84 $2.03 Million - $2.37 Million
6,333 New
6,333 $2.15 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $69.8B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Geneva Partners, LLC Portfolio

Follow Geneva Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Partners, LLC with notifications on news.